Start for free
Start for free
HBM Healthcare Investments logo

HBM Healthcare Investments

Europe, Zug, Switzerland, Zug

Description

HBM Healthcare Investments finances companies related to human medicine, biotechnology, medical technology, and diagnostics sectors.

Investor Profile

HBM Healthcare Investments has made 250 investments, with 8 in the past 12 months and 19% as lead.

Stage Focus

  • Series B (23%)
  • Series C (22%)
  • Series A (12%)
  • Series Unknown (12%)
  • Series D (9%)
  • Convertible Note (8%)
  • Series E (5%)
  • Post Ipo Equity (3%)
  • Private Equity (2%)
  • Debt Financing (1%)

Country Focus

  • United States (63%)
  • Germany (8%)
  • Switzerland (8%)
  • China (4%)
  • Canada (4%)
  • India (3%)
  • Colombia (2%)
  • Denmark (2%)
  • Israel (1%)
  • United Kingdom (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Medical Device
  • Biopharma
  • Life Science
  • Health Diagnostics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does HBM Healthcare Investments frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 29
Novartis Venture Fund
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 11
CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 29
HBM Partners
HBM Partners
Europe, Zug, Switzerland, Zug
Co-Investments: 18
RTW Investments
RTW Investments
North America, New York, United States, New York
Co-Investments: 11
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 15
Novo Holdings
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 18
SR One
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 12
Alta Partners
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 13
OUP (Osage University Partners)
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 11

Which angels does HBM Healthcare Investments often collaborate with?

LC
Lawrence C. Best
North America, Massachusetts, United States, Boston
Shared Deals: 1
HT
Henri Termeer
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1
Rubal Jain
Rubal Jain
Asia, Delhi, India, New Delhi
Shared Deals: 1
TA
Timothy A. Springer
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
SP
Stelios Papadopoulos
Europe, Germany
Shared Deals: 1
FM
Frank Moss
North America, United States
Shared Deals: 1
Vardaan Sharma
Vardaan Sharma
Asia, Punjab, India, Ludhiana
Shared Deals: 1
SH
Steven Holtzman
North America, New Hampshire, United States, Center Harbor
Shared Deals: 1

What are some of recent deals done by HBM Healthcare Investments?

Curevo

Bothell, Washington, United States

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

BiopharmaBiotechnologyHealth CareMedical
Series BMar 17, 2025
Amount Raised: $110,000,000
Numab

Wadenswil, Zurich, Switzerland

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

BiopharmaBiotechnologyHealth CareHealth DiagnosticsLife ScienceMedicalTherapeutics
Series CJan 9, 2025
Amount Raised: $54,939,501
Molecular Partners

Zürich, Zurich, Switzerland

Molecular Partners is a clinical-stage biopharmaceutical company.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityOct 25, 2024
Amount Raised: $20,000,000
Sphingotec GmbH

Hohen Neuendorf, Brandenburg, Germany

SphingoTec develops innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions.

Biotechnology
Series CAug 8, 2024
Amount Raised: $5,469,089
Chemomab

Tel Aviv, Tel Aviv, Israel

Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityJul 25, 2024
Amount Raised: $10,000,000
Cartesian Therapeutics

Gaithersburg, Maryland, United States

Pioneering Potent, Safer Cell Therapy in and Beyond Oncology

BiotechnologyOncology
Post Ipo EquityJul 2, 2024
Amount Raised: $130,000,000
Bluejay Therapeutics

San Mateo, California, United States

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

BiotechnologyHealth CarePharmaceutical
Series CMay 9, 2024
Amount Raised: $182,000,000
Karius

Redwood City, California, United States

Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.

BiotechnologyGeneticsHealth CareInformation TechnologyLife SciencePrecision Medicine
Series CMay 2, 2024
Amount Raised: $100,000,000
Alumis

San Francisco, California, United States

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

BiotechnologyHealth CareLife SciencePrecision Medicine
Series CMar 6, 2024
Amount Raised: $259,000,000
Shape Memory Medical

Santa Clara, California, United States

Shape Memory Medical is a medical device company that develops innovative medical devices based on Shape Memory Polymer (SMP) materials.

Health CareMedical DeviceTherapeutics
Series CMar 4, 2024
Amount Raised: $38,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator